Relton Clare, Cooper Katy, Viksveen Petter, Fibert Philippa, Thomas Kate
School of Health and Related Research (ScHARR), University of Sheffield, UK.
Homeopathy. 2017 May;106(2):69-78. doi: 10.1016/j.homp.2017.03.002. Epub 2017 Apr 7.
To systematically review surveys of 12-month prevalence of homeopathy use by the general population worldwide.
Studies were identified via database searches to October 2015. Study quality was assessed using a six-item tool. All estimates were in the context of a survey which also reported prevalence of any complementary and alternative medicine use.
A total of 36 surveys were included. Of these, 67% met four of six quality criteria. Twelve-month prevalence of treatment by a homeopath was reported in 24 surveys of adults (median 1.5%, range 0.2-8.2%). Estimates for children were similar to those for adults. Rates in the USA, UK, Australia and Canada all ranged from 0.2% to 2.9% and remained stable over the years surveyed (1986-2012). Twelve-month prevalence of all use of homeopathy (purchase of over-the-counter homeopathic medicines and treatment by a homeopath) was reported in 10 surveys of adults (median 3.9%, range 0.7-9.8%) while a further 11 surveys which did not define the type of homeopathy use reported similar data. Rates in the USA and Australia ranged from 1.7% to 4.4% and remained stable over the years surveyed. The highest use was reported by a survey in Switzerland where homeopathy is covered by mandatory health insurance.
This review summarises 12-month prevalence of homeopathy use from surveys conducted in eleven countries (USA, UK, Australia, Israel, Canada, Switzerland, Norway, Germany, South Korea, Japan and Singapore). Each year a small but significant percentage of these general populations use homeopathy. This includes visits to homeopaths as well as purchase of over-the-counter homeopathic medicines.
系统综述全球普通人群使用顺势疗法的12个月患病率调查。
通过数据库检索确定截至2015年10月的研究。使用一个六项工具评估研究质量。所有估计值均基于一项同时报告了任何补充和替代医学使用患病率的调查。
共纳入36项调查。其中，67%符合六项质量标准中的四项。24项成人调查中报告了接受顺势疗法治疗的12个月患病率（中位数为1.5%，范围为0.2%-8.2%）。儿童的估计值与成人相似。美国、英国、澳大利亚和加拿大的患病率均在0.2%至2.9%之间，且在调查年份（1986 - 2012年）保持稳定。10项成人调查中报告了所有顺势疗法使用（购买非处方顺势疗法药物和接受顺势疗法治疗）的12个月患病率（中位数为3.9%，范围为0.7%-9.8%），另有11项未明确顺势疗法使用类型的调查报告了类似数据。美国和澳大利亚的患病率在1.7%至4.4%之间，且在调查年份保持稳定。瑞士的一项调查报告的使用率最高，该国顺势疗法由强制性医疗保险覆盖。
本综述总结了在11个国家（美国、英国、澳大利亚、以色列、加拿大、瑞士、挪威、德国、韩国、日本和新加坡）进行的调查中顺势疗法使用的12个月患病率。每年这些普通人群中有一小部分但相当比例的人使用顺势疗法。这包括拜访顺势疗法医生以及购买非处方顺势疗法药物。
